Luo, Chuanfang
Yu, Shuhui
Zhang, Jinping
Wu, Xingrao
Dou, Zhongyan
Li, Zheng
Yang, E.
Zhang, Lan
Funding for this research was provided by:
Innovation Team of Molecular Diagnosis and Treatment of Cervical Cancer in Kunming Medical University (CXTD201906)
National Natural Science Foundation of China (81802614, 82160562)
Applied Basic Research Projects of Yunnan Province, China (2019FD090)
Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University (2019FE001(-151))
Medical Reserve Personnel Training Plan of Yunnan Provincial Health Commission (HN2018-10)
Foundation of 100 Young and Middle-aged Academic, Technical Backbone of Kunming Medical University (60118260117)
Article History
Received: 18 March 2022
Accepted: 13 October 2022
First Online: 1 November 2022
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Yunnan Cancer Hospital (NO. KYLX2022033). Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.